Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of MMPI-2 Validity Scales Among Compensation-Seeking Caucasian and Asian American Medical Patients

View through CrossRef
Validity scales of the Minnesota Multiphasic Personality Inventory—2 (MMPI-2) are widely used for the detection of exaggerated psychological complaints, although little is known about the results of these scales with racial or ethnic minority individuals. Five validity scales derived from the MMPI-2, including the F Scale, the Back Infrequency Scale, the Symptom Validity Scale, the Infrequency-Psychopathology Scale, and the Dissimulation Scale-MMPI-2, were evaluated in 157 medical patients—109 Caucasian Americans and 48 Asian Americans. All patients were involved in personal injury litigation or seeking compensation for alleged psychological conditions. Analyses of variance (ANOVAs) conducted on the five validity scales revealed no significant group effects for race. The results were consistent with the limited available data on the MMPI-2 validity scales with minority group samples. Further research with other racial minorities, including relevant extra-test criteria for malingering, is encouraged.
Title: Comparison of MMPI-2 Validity Scales Among Compensation-Seeking Caucasian and Asian American Medical Patients
Description:
Validity scales of the Minnesota Multiphasic Personality Inventory—2 (MMPI-2) are widely used for the detection of exaggerated psychological complaints, although little is known about the results of these scales with racial or ethnic minority individuals.
Five validity scales derived from the MMPI-2, including the F Scale, the Back Infrequency Scale, the Symptom Validity Scale, the Infrequency-Psychopathology Scale, and the Dissimulation Scale-MMPI-2, were evaluated in 157 medical patients—109 Caucasian Americans and 48 Asian Americans.
All patients were involved in personal injury litigation or seeking compensation for alleged psychological conditions.
Analyses of variance (ANOVAs) conducted on the five validity scales revealed no significant group effects for race.
The results were consistent with the limited available data on the MMPI-2 validity scales with minority group samples.
Further research with other racial minorities, including relevant extra-test criteria for malingering, is encouraged.

Related Results

Psychological complications of patients with Gaucher disease
Psychological complications of patients with Gaucher disease
SummaryThe Minnesota Multiphasic Personality Inventory (MMPI‐2) is commonly used in chronic illness and chronic pain populations to assess psychological functioning. We report the ...
Psychological aspects of patients with Fabry disease
Psychological aspects of patients with Fabry disease
SummaryThe Minnesota Muliphasic Personality Inventory (MMPI‐2) is widely used in chronic illness and chronic pain populations to assess psychological functioning. We report the res...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Assessing Adolescents with the MMPI-A
Assessing Adolescents with the MMPI-A
AbstractThe MMPI-A is a sophisticated self-report instrument that allows clinicians to assess psychopathology in adolescent clients despite complex developmental, clinical, and met...
Caucasian Xenoglossary in Modern Russian and Image of “Caucasian World”
Caucasian Xenoglossary in Modern Russian and Image of “Caucasian World”
The Caucasus has always been of interest for Russia. Russian-Caucasian contacts are being studied in political, economic, religious and social aspects. But linguistic horizon has n...
Mindy Calling: Size, Beauty, Race in The Mindy Project
Mindy Calling: Size, Beauty, Race in The Mindy Project
When characters in the Fox Television sitcom The Mindy Project call Mindy Lahiri fat, Mindy sees it as a case of misidentification. She reminds the character that she is a “petite ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top